Key points are not available for this paper at this time.
TANs recruit macrophages and Treg cells to HCCs to promote their growth, progression, and resistance to sorafenib.
Zhou et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: